Christopher J. Carbone, Ph.D.
Affiliations: | 2007 | Temple University, Philadelphia, PA, United States |
Area:
Molecular Biology, GeneticsGoogle:
"Christopher Carbone"Parents
Sign in to add mentor| Dale Haines | grad student | 2007 | Temple University | |
| (p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2 mediated anchorage independent growth of oncogene-transduced primary mouse fibroblasts.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ortiz A, Gui J, Zahedi F, et al. (2019) An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles. Cancer Cell. 35: 33-45.e6 |
| Katlinski KV, Gui J, Katlinskaya YV, et al. (2017) Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment. Cancer Cell. 31: 194-207 |
| Katlinskaya YV, Carbone CJ, Yu Q, et al. (2015) Type 1 interferons contribute to the clearance of senescent cell. Cancer Biology & Therapy. 16: 1214-9 |
| Yu Q, Katlinskaya YV, Carbone CJ, et al. (2015) DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function. Cell Reports. 11: 785-97 |
| Bhattacharya S, Katlinski KV, Reichert M, et al. (2014) Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury. Embo Molecular Medicine. 6: 384-97 |
| Carbone CJ, Fuchs SY. (2014) Eliminative signaling by Janus kinases: role in the downregulation of associated receptors. Journal of Cellular Biochemistry. 115: 8-16 |
| Zheng H, Gupta V, Patterson-Fortin J, et al. (2013) A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses. Cell Reports. 5: 180-93 |
| Carbone CJ, Varghese B, Zheng H, et al. (2013) 33 Cytokine. 63: 251 |
| Carbone CJ, Zheng H, Bhattacharya S, et al. (2012) Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies. Proceedings of the National Academy of Sciences of the United States of America. 109: 19226-31 |
| Zheng H, Qian J, Carbone CJ, et al. (2011) Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis. Blood. 118: 4003-6 |